Cergentis
Menu

Webinars

TLA: Improved QC for upstream and downstream cell and gene therapy manufacturing
TLA: Improved genetic characterisation and clonality assessment for (CHO) cell line development
TLA technology & targeted complete NGS of genes and gene fusions in leukaemia
TLA-based targeted transgene & integration site sequencing
TLA technology & complete NGS of transgenes, integration sites and gene editing events
Applications & principles of TLA-based complete sequencing and haplotyping
© 2012-2020 Cergentis B.V. All rights reserved.
For Research Use Only.Not for use in diagnostic procedures.